Clinical Services > Pharmacy

Metabolic hormone leptin linked to vaccine response

31 May, 2021 by Amy Sarcevic

Reduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.

New COVID-19 vaccine completely blocks viral transmission

19 May, 2021 by Amy Sarcevic

An Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.

Historic PBS listing of cannabis for Dravet syndrome

10 May, 2021

Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.

New national standard for intensive care pharmacists

05 May, 2021

The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.

Evidence urgently needed on how to safely withdraw patients from antidepressants

03 May, 2021 by Amy Sarcevic

Researchers at the Cochrane Collaboration reviewed 33 studies involving nearly 5000 participants, relating to antidepressant discontinuation.

Putting pharmacists where they're needed most

27 April, 2021 by Kristin Michaels, SHPA CEO

SHPA will continue to advocate for investment in embedding geriatric medicine pharmacists as part of clinical pharmacy services for aged-care residents.

The collaboration igniting malaria drug discovery

27 April, 2021

Johnson & Johnson Innovation has facilitated a collaboration between WEHI and Janssen Pharmaceutica NV to ignite the development of antimalarial drug candidates.

AstraZeneca vaccine myths debunked

14 April, 2021 by Amy Sarcevic

Australians are being reminded that a causal relationship between blood clotting and adenovirus vector-based vaccines has still not been established, and that — should it be — the risk remains far lower than that of common medications.

New cell-based flu vaccine to be rolled out this month

07 April, 2021 by Amy Sarcevic

This winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.

Pausing the vaccine rollout will claim, not protect, lives, says Professor

22 March, 2021 by Amy Sarcevic

Countries that have opted to pause the AstraZeneca vaccine amid unsubstantiated blood clotting fears are actively choosing to end lives, according to Professor Bruce Thompson.

Compulsory vaccines possible but unlikely, says law professor

08 March, 2021 by Amy Sarcevic

Whatever the government's intention, Prof Stewart believes a mandate should be the "final instrument" in its quest to roll out a vaccination program.

New MS treatment available on PBS

04 March, 2021

Australians living with relapsing-remitting multiple sclerosis can now access a new treatment option with the listing of Zeposia (ozanimod) on the PBS.

Managing medication in aged care

19 February, 2021 by Amy Sarcevic

These days, pharmaceuticals and aged care tend to go hand in hand, but with 95% of aged-care residents living with a medication-induced problem, the relationship is far from harmonious.

Vaccine rollout may face delays

11 February, 2021 by Amy Sarcevic

Insufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world.

Active ingredient prescribing comes into effect

04 February, 2021 by Matthew Grant, Monash University

Doctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd